Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/04/23
End: 03/31/27
Due: 03/31/28
Phase: N/A
Priority: Normal
Start: 05/31/15
End: 08/31/16
Due: 08/31/17
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative Neoplasm | NCT05025488 | Marina Kremyanskaya | user2@example.com | None | 2023-04-04 | 2027-03-31 | 2028-03-31 | - | - | 2025-07-14 |
| Ruxolitinib in Combination With Autotransplant | NCT02469974 | Marina Kremyanskaya | user2@example.com | None | 2015-05-31 | 2016-08-31 | 2017-08-31 | - | - | 2025-07-14 |